UNASSIGNED: Overall, 184 subjects who were pathologically diagnosed with SCLC were enrolled in the study. Immunohistochemical analysis of PAX8 and Ki-67 were performed. The correlations between PAX8 expression and clinical features or Ki-67 index were further analyzed. Subsequently, an analysis of the association between PAX8, stage, Ki-67 status, and overall survival (OS) were performed in 169 subjects with follow-up information.
UNASSIGNED: PAX8 was positive in 53.8% (99/184) SCLC specimens. The positive rate is significantly higher in extensive-stage specimens (61.0%) than in limited-stage specimens (45.24%). PAX8 expression is positively correlated with Ki-67 index (P = 0.001) while negatively correlated with OS (HR = 3.725, 95% CI 1.943-7.139, P<0.001). In combination groups, the PAX8 negative and limited stage group had the most promising OS.
UNASSIGNED: PAX8 expression rate in SCLC specimens is not low. It has prognostic value in small cell lung cancer.
■总的来说,184名病理诊断为SCLC的受试者被纳入研究。对PAX8和Ki-67进行免疫组织化学分析。进一步分析PAX8表达与临床特征或Ki-67指数的相关性。随后,分析PAX8,阶段,Ki-67状态,和总生存期(OS)的169名受试者进行了随访信息。
■PAX8在53.8%(99/184)SCLC样本中是阳性的。广泛阶段标本的阳性率(61.0%)明显高于有限阶段标本(45.24%)。PAX8表达与Ki-67指数呈正相关(P=0.001),与OS呈负相关(HR=3.725,95%CI1.943~7.139,P<0.001).在组合组中,PAX8阴性和有限阶段组的OS最有希望.
■PAX8在SCLC标本中的表达率并不低。它在小细胞肺癌中具有预后价值。